Author Correction: The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome

• Emanuela Sozio,
• Juliane Hannemann,
• Martina Fabris,
• Adriana Cifù,
• Andrea Ripoli,
• Francesco Sbrana,
• Demetrio Cescutti,
• Luigi Vetrugno,
• Stefano Fapranzi,
• Flavio Bassi,
• Massimo Sponza,
• Francesco Curcio,
• Carlo Tascini,
• Rainer Böger

Affiliations

Emanuela Sozio

Infectious Diseases Clinic, Azienda Sanitaria Universitaria del Friuli Centrale (ASUFC)

Juliane Hannemann

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf

Martina Fabris

Istituto di Patologia Clinica, Azienda Sanitaria Universitaria Friuli Centrale - Udine (ASUFC)

Adriana Cifù

Department of Medical Area (DAME), University of Udine

Andrea Ripoli

Bioengineering Department, Fondazione Toscana Gabriele Monasterio

Francesco Sbrana

Lipoapheresis Unit - Reference Center for Diagnosis and Treatment of Inherited Dyslipidemias, Fondazione Toscana “Gabriele Monasterio”

Demetrio Cescutti

Infectious Diseases Clinic, Azienda Sanitaria Universitaria del Friuli Centrale (ASUFC)

Luigi Vetrugno

Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara

Stefano Fapranzi

Emergency Radiology Department - Azienda Sanitaria, Universitaria del Friuli Centrale (ASUFC)

Flavio Bassi

Department of Anesthesia and Intensive Care Medicine, Azienda Sanitaria Universitaria Friuli Centrale - Udine (ASUFC)

Massimo Sponza

Emergency Radiology Department - Azienda Sanitaria, Universitaria del Friuli Centrale (ASUFC)

Francesco Curcio

Istituto di Patologia Clinica, Azienda Sanitaria Universitaria Friuli Centrale - Udine (ASUFC)

Carlo Tascini

Infectious Diseases Clinic, Azienda Sanitaria Universitaria del Friuli Centrale (ASUFC)

Rainer Böger

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf